IVF breakthrough? new study tests simpler drug protocol for PCOS
NCT ID NCT05326087
Summary
This study aims to find out which of two common medication plans works better for women with PCOS undergoing IVF with genetic testing. Researchers will compare a newer, simpler oral medication plan (PPOS) against a standard injectable plan (GnRH antagonist). The main goal is to see which plan helps produce more genetically normal embryos, potentially leading to healthier pregnancies and babies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREIMPLANTATION GENETIC TESTING are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Conditions
Explore the condition pages connected to this study.